Current opinion in pediatric heart transplantation

Area of Science:

• Pediatric cardiology
• Transplant medicine
• Congenital heart disease

Background:

• Pediatric cardiac transplant is the leading therapy for end-stage heart disease.
• Limited donor organ availability leads to high waitlist mortality.
• Increasing demand strains the organ supply chain.

Purpose of the Study:

• To review recent strategies addressing donor organ limitations in pediatric heart transplantation.
• To highlight novel approaches for improving waitlist outcomes and organ utilization.
• To discuss challenges posed by an aging congenital heart disease population.

Main Methods:

• Analysis of updated pediatric heart allocation systems (2016).
• Review of risk-stratification and donor-specific factor importance.
• Examination of increased Ventricular Assist Device (VAD) use and novel techniques like pulmonary artery banding.

Main Results:

• The 2016 allocation system prioritizes high-risk children and optimizes organ use.
• Studies support risk-stratification and donor factor assessment.
• Increased VAD use and innovative surgical techniques show promise in reducing waitlist mortality.

Conclusions:

• Pediatric cardiac transplant offers excellent outcomes but faces organ shortages.
• Judicious listing, maximal organ utilization, and waitlist support are crucial.
• Addressing new demands requires continued innovation and system adaptation.